We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+0.86%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$180M
AUM Growth
-$37.8M
Cap. Flow
+$347K
Cap. Flow %
0.19%
Top 10 Hldgs %
61.88%
Holding
41
New
8
Increased
3
Reduced
3
Closed
4

Top Buys

Rank Stock Value
1
PHYS icon
Sprott Physical Gold
PHYS
+$14.3M
2
OR icon
OR Royalties Inc
OR
+$9.24M
3
PSLV icon
Sprott Physical Silver Trust
PSLV
+$6.06M
4
GROY icon
Gold Royalty Corp
GROY
+$4.27M
5
TFPM icon
Triple Flag Precious Metals
TFPM
+$2.03M

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$12.9M
2
GLD icon
SPDR Gold Trust
GLD
+$12.7M
3
SLV icon
iShares Silver Trust
SLV
+$5.15M
4
ALT icon
Altimmune
ALT
+$4.08M
5
KGC icon
Kinross Gold
KGC
+$2.95M

Sector Composition

Rank Sector Weight
1 Materials 48.74%
2 Healthcare 37.4%
3 Industrials 1.38%
4 Consumer Staples 0.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$19.7M 10.93%
2,328,602
– –
PHYS icon
2
Sprott Physical Gold
PHYS
$14.6B
$13.7M 7.61%
+387,055
New +$14.3M
RGLD icon
3
Royal Gold
RGLD
$17.1B
$13.4M 7.45%
52,750
– –
MGTX icon
4
MeiraGTx Holdings
MGTX
$1.09B
$10.8M 6.01%
1,250,000
– –
AEM icon
5
Agnico Eagle Mines
AEM
$72.6B
$10.7M 5.94%
52,750
– –
KGC icon
6
Kinross Gold
KGC
$28.5B
$9.77M 5.42%
320,000
-90,000
-22% -$2.95M
ALDX icon
7
Aldeyra Therapeutics
ALDX
$91.7M
$9.25M 5.14%
5,475,516
– –
SA
8
Seabridge Gold
SA
$2.8B
$8.98M 4.99%
317,003
– –
FNV icon
9
Franco-Nevada
FNV
$41.4B
$7.91M 4.39%
32,000
+7,000
+28% +$1.73M
SSRM icon
10
SSR Mining
SSRM
$5.57B
$7.2M 4%
245,000
– –
ELTX icon
11
Elicio Therapeutics
ELTX
$78.8M
$6.74M 3.74%
630,915
– –
ENTX icon
12
Entera Bio
ENTX
$101M
$6.47M 3.59%
5,881,879
– –
NUVB icon
13
Nuvation Bio
NUVB
$2.24B
$6.43M 3.57%
1,498,591
– –
CGAU
14
Centerra Gold
CGAU
$3.22B
$6.39M 3.54%
359,000
-138,402
-28% -$2.46M
PAAS icon
15
Pan American Silver
PAAS
$18.6B
$5.46M 3.03%
100,035
– –
PSLV icon
16
Sprott Physical Silver Trust
PSLV
$11.9B
$5.42M 3.01%
+222,160
New +$6.06M
OCUL icon
17
Ocular Therapeutix
OCUL
$1.86B
$5.09M 2.82%
600,400
– –
TFPM icon
18
Triple Flag Precious Metals
TFPM
$6B
$3.99M 2.22%
115,000
+56,200
+96% +$2.03M
GROY icon
19
Gold Royalty Corp
GROY
$593M
$3.58M 1.99%
+1,000,000
New +$4.27M
AGI icon
20
Alamos Gold
AGI
$12.4B
$2.22M 1.23%
50,000
– –
ABEO icon
21
Abeona Therapeutics
ABEO
$345M
$2.18M 1.21%
485,515
+249,562
+106% +$1.25M
NEWP
22
New Pacific Metals
NEWP
$833M
$2.01M 1.11%
485,000
– –
CDE icon
23
Coeur Mining
CDE
$15.6B
$1.8M 1%
96,132
– –
ITA icon
24
iShares US Aerospace & Defense ETF
ITA
$14.2B
$1.67M 0.93%
7,650
– –
PM icon
25
Philip Morris
PM
$301B
$1.65M 0.92%
10,000
– –
1
2

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, Knoll Capital Management held 41 positions worth $180M, down 17% from $218M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Knoll Capital Management's Q1 2026 filing shows 8 new, 3 increased, 3 reduced and 4 closed positions. Its largest new stake was Sprott Physical Gold: 387,055 shares worth $13.7M. The largest sale was Avadel Pharmaceuticals, an estimated $12.9M.

By sector, the portfolio is most concentrated in Materials at 49% of assets, up from 34% a quarter earlier, followed by Healthcare and Industrials.

  • Knoll Capital Management's largest Q1 2026 buy was Sprott Physical Gold: 387,055 shares worth $13.7M.
  • Knoll Capital Management added most to Triple Flag Precious Metals in Q1 2026, an estimated $2.03M increase.
  • Knoll Capital Management's biggest Q1 2026 reduction was Altimmune, cutting an estimated $4.08M.
  • Knoll Capital Management fully exited Avadel Pharmaceuticals in Q1 2026, selling an estimated $12.9M.
  • Knoll Capital Management's ten largest holdings make up 62% of its $180M portfolio in Q1 2026.
  • Knoll Capital Management opened 8 new positions and closed 4 in Q1 2026.
  • Knoll Capital Management's portfolio value fell 17% quarter-over-quarter to $180M.

Based on Knoll Capital Management's 13F filing for Q1 2026, filed 15 May 2026.